Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Risk-stratification of B-precursor acute lymphoblastic leukemia patients

Risk-stratification of B-precursor acute lymphoblastic leukemia patients

US Patent 11079381 · Granted Aug 3, 2021

Estimated economic value: $105,290,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody constructs for CDH19 and CD32025
Antibody constructs for DLL3 and CD32025
PSMA and CD3 bispecific T cell engaging antibody constructs2025
Antibody constructs for DLL3 and CD32025
Antibody constructs for CDH19 and CD32025
Cross-species-specific PSMAxCD3 bispecific single chain antibody2025
Binding molecules for BCMA and CD32025
Binding molecules for BCMA and CD32025
Nucleic acids encoding anitbody constructs binding EGFR VIII and CD32024
Cross-species-specific single domain bispecific single chain antibody2024
Compositions comprising cross-species-specific antibodies and uses thereof2024
Bispecific antibody constructs for CDH3 and CD32024